首页 | 本学科首页   官方微博 | 高级检索  
检索        


Thyroid dysfunction in primary biliary cirrhosis,primary sclerosing cholangitis and non‐alcoholic fatty liver disease
Authors:Marina G Silveira  Flavia D Mendes  Nancy N Diehl  Felicity T Enders  Keith D Lindor
Institution:1. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA;2. Division of Hepatology, University of Miami Miller School of Medicine, Miami, FL, USA;3. Division of Biostatistics, Mayo Clinic, Jacksonville, FL, USA;4. Division of Biostatistics, Mayo Clinic, Rochester, MN, USA
Abstract:Background/Aims: Primary biliary cirrhosis (PBC) is frequently associated with autoimmune diseases, including thyroid disease, although it is uncertain that this association is higher than in other liver diseases. Methods: We compared the prevalence and incidence of thyroid dysfunction (TD) in a series of patients with PBC (n=67) with patients with primary sclerosing cholangitis (PSC) (n=79) and non‐alcoholic fatty liver disease (NAFLD) (n=97) seen in a tertiary referral centre who had previously participated in clinical trials. Results: At initial evaluation, prevalence of TD in PBC was 13% compared with 11% in PSC (P=0.71) and 25% in NAFLD (P=0.08). Incidence of TD was 2.9 patients per 100 person‐years in PBC compared with 2.1 patients per 100 person‐years in PSC (P=0.57) and 1.8 patients per 100 person‐years in non‐alcoholic liver disease (P=0.45). Older age, female gender, biochemical abnormalities and concurrent autoimmune disorders were not predictive of the development of TD. Conclusions: TD was unexpectedly as common in patients with PBC as in patients with PSC and NAFLD, yet significantly more common than expected in the general population. Further investigation of thyroid disease in PSC and NAFLD is warranted.
Keywords:autoimmune diseases  autoimmune liver diseases  thyroid disease
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号